Evidence
Ageing Res Rev. 2024 Feb 13:102233. doi: 10.1016/j.arr.2024.102233. Online ahead of print.
ABSTRACT
The ketogenic diet (KD) is a low-carbohydrate, adequate protein and high-fat diet. KD is primarily used to treat refractory epilepsy. KD was shown to be effective in treating different neurodegenerative diseases. Alzheimer disease (AD) is the first common neurodegenerative disease in the world characterized by memory and cognitive impairment. However, the underlying mechanism of KD in controlling of AD and other neurodegenerative diseases are not discussed widely. Therefore, this review aims to revise the fundamental mechanism of KD in different neurodegenerative diseases focusing on the AD. KD induces a fasting-like which modulates the central and peripheral metabolism by regulating mitochondrial dysfunction, oxidative stress, inflammation, gut-flora, and autophagy in different neurodegenerative diseases. Different studies highlighted that KD improves AD neuropathology by regulating synaptic neurotransmission and inhibiting of neuroinflammation and oxidative stress. In conclusion, KD improves cognitive function and attenuates the progression of AD neuropathology by reducing oxidative stress, mitochondrial dysfunction, and enhancing neuronal autophagy and brain BDNF.
PMID:38360180 | DOI:10.1016/j.arr.2024.102233
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
🌐 90 Days
VR Related Evidence Matrix
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Neurotoxicity of Pyrethroids in exacerbating neurodegenerative diseases: From animals' models to humans' studies
- Are age-related neurodegenerative diseases caused by a lack of the diet-derived compound ergothioneine?
- The complement system in neurodegenerative diseases
- Gastroesophageal reflux disease with 6 neurodegenerative and psychiatric disorders: Genetic correlations, causality, and potential molecular mechanisms
- Innate immune activation in neurodegenerative diseases
- Clinical Arterial Spin-Labeling MR Imaging to Screen for Typical and Atypical Neurodegenerative Disease in the New Era of Alzheimer Treatment
- Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure
- Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis
- NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer
- NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer
- A lupin protein hydrolysate protects the central nervous system from oxidative stress in WD-fed ApoE-/- mice
- A lupin protein hydrolysate protects the central nervous system from oxidative stress in WD-fed ApoE-/- mice
- Disentangling tau: One protein, many therapeutic approaches
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
- Brain energetics and glucose transport in metabolic diseases: role in neurodegeneration
- Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases
- Linguistic changes in neurodegenerative diseases relate to clinical symptoms
- Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
- Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
- Targeting N-Methyl-d-Aspartate Receptors in Neurodegenerative Diseases
- Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue
- Memory diseases
- Understanding age-related pathologic changes in TDP-43 functions and their consequence on RNA splicing and signalling in health and disease
- The MIND diet for the ageing brain: a systematic review
- Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
- Accumulation of neutral lipids in dystrophic neurites surrounding amyloid plaques in Alzheimer's disease
- Anorexigenic neuropeptides as anti-obesity and neuroprotective agents
- Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Review of MR spectroscopy analysis and artificial intelligence applications for the detection of cerebral inflammation and neurotoxicity in Alzheimer's disease
- Dietary and Metabolic Approaches for Treating Autism Spectrum Disorders, Affective Disorders and Cognitive Impairment Comorbid with Epilepsy: A Review of Clinical and Preclinical Evidence
- The Contribution of Microglia and Brain-Infiltrating Macrophages to the Pathogenesis of Neuroinflammatory and Neurodegenerative Diseases during TMEV Infection of the Central Nervous System
- Transcriptomics of Human Brain Tissue in Parkinson's Disease: a Comparison of Bulk and Single-cell RNA Sequencing
- Palliative Care Interventions for Persons With Neurodegenerative Disease: A Scoping Review of Clinical Trial Study Design Features
- Potential Convergence of Olfactory Dysfunction in Parkinson's Disease and COVID-19: The Role of Neuroinflammation
- Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson's disease and synucleinopathies
- Partial loss of MCU mitigates pathology in vivo across a diverse range of neurodegenerative disease models
- Sex-specific neuropsychological correlates of apathy and depression across neurodegenerative disorders
- Dissecting Parkinson's disease with long-read RNA-sequencing
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- Cerebellum and Aging: Update and Challenges
- Unraveling the Dual Role of ADAM10: Bridging the Gap between Cancer and Alzheimer's Disease
- Loss of GDE2 leads to complex behavioral changes including memory impairment
- Porphyromonas gingivalis, neuroinflammation and Alzheimer's disease
- Vitamin K2 protects mice against non-alcoholic fatty liver disease induced by high-fat diet
- Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer's disease
- Pathological C-terminal phosphomimetic substitutions alter the mechanism of liquid-liquid phase separation of TDP-43 low complexity domain
- Alzheimer's Drugs APPlication for Down syndrome?
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Alzheimer's Disease Diagnosis in the Preclinical Stage: Normal Aging or Dementia
- Pathogenic Potential of Eomesodermin-Expressing T-Helper Cells in Neurodegenerative Diseases
- Sex-Specific Effects of Ketogenic Diet on Anxiety-like Behavior and Neuroimmune Response in C57Bl/6J Mice
- The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
- Emerging functions and therapeutic targets of IL-38 in central nervous system diseases
- Emerging functions and therapeutic targets of IL-38 in central nervous system diseases
- Psychedelics for Alzheimer's Disease-Related Dementia: Unveiling Therapeutic Possibilities and Pathways
- Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders
- Role of prolactin in the protective effect of amisulpride against 1,2-Diacetylbenzene's neurotoxicity
- Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse prevention
- The role of P2Y6 receptor in the pathogenesis of cardiovascular and inflammatory diseases
Evidence Blueprint
Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
🌐 365 Days
VR Related Evidence Matrix
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Neurotoxicity of Pyrethroids in exacerbating neurodegenerative diseases: From animals' models to humans' studies
- Repercussion of Primary Nucleation Pathway: Dementia and Cognitive Impairment
- Let Us Talk Money: Subjectively Reported Financial Performance of People Living with Neurodegenerative Diseases-A Systematic Review
- Are age-related neurodegenerative diseases caused by a lack of the diet-derived compound ergothioneine?
- Phenotype parallels protein seeding capacity in neurodegenerative diseases
- Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
- The complement system in neurodegenerative diseases
- Gastroesophageal reflux disease with 6 neurodegenerative and psychiatric disorders: Genetic correlations, causality, and potential molecular mechanisms
- Disrupting pathologic phase transitions in neurodegeneration
- Local genetic correlations exist among neurodegenerative and neuropsychiatric diseases
- Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
- Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework
- Innate immune activation in neurodegenerative diseases
- Clinical Arterial Spin-Labeling MR Imaging to Screen for Typical and Atypical Neurodegenerative Disease in the New Era of Alzheimer Treatment
- Rare neurovascular genetic and imaging markers across neurodegenerative diseases
- Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders
- Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer's Disease and Parkinson's Disease
- Regional genetic correlations highlight relationships between neurodegenerative disease loci and the immune system
- Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry
- Incidence and morphology of secondary TDP-43 proteinopathies: Part 2
- Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure
- Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis
- NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer
- NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer
- A lupin protein hydrolysate protects the central nervous system from oxidative stress in WD-fed ApoE-/- mice
- A lupin protein hydrolysate protects the central nervous system from oxidative stress in WD-fed ApoE-/- mice
- The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases
- Disentangling tau: One protein, many therapeutic approaches
- Predicting neurodegeneration from sleep related biofluid changes
- Common microRNA regulated pathways in Alzheimer's and Parkinson's disease
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
- Blood-Brain Barrier Disruption and Perivascular Spaces in Small Vessel Disease and Neurodegenerative Diseases: A Review on MRI Methods and Insights
- Pathology of neurodegenerative disease for the general neurologist
- Brain energetics and glucose transport in metabolic diseases: role in neurodegeneration
- The Relationship of Ketogenic Diet with Neurodegenerative and Psychiatric Diseases: A Scoping Review from Basic Research to Clinical Practice
- Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases
- Linguistic changes in neurodegenerative diseases relate to clinical symptoms
- Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
- Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
- Purinergic receptors in cognitive disturbances
- Targeting N-Methyl-d-Aspartate Receptors in Neurodegenerative Diseases
- The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration
- Cellular and animal models to investigate pathogenesis of amyloid aggregation in neurodegenerative diseases
- Ketogenic diet ameliorates autism spectrum disorders-like behaviors via reduced inflammatory factors and microbiota remodeling in BTBR mice
- Targeting NLRP3 inflammasome for neurodegenerative disorders
- Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue
- Psychobiotics for Mitigation of Neuro-Degenerative Diseases: Recent Advancements
- The gut-brain vascular axis in neuroinflammation
- White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases
- Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease
- Memory diseases
- High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?
- Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study
- Neural Cells for Neurodegenerative Diseases in Clinical Trials
- Understanding age-related pathologic changes in TDP-43 functions and their consequence on RNA splicing and signalling in health and disease
- Changes in iron load in specific brain areas lead to neurodegenerative diseases of the central nervous system
- Connecting the Gut Microbiota and Neurodegenerative Diseases: the Role of Bile Acids
- The MIND diet for the ageing brain: a systematic review
- Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
- Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases
- Accumulation of neutral lipids in dystrophic neurites surrounding amyloid plaques in Alzheimer's disease